MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about schizophrenia

Recent news which mentions schizophrenia

Taye Diggs: My sister's schizophrenia diagnosis changed our family—and how I handle my own anxiety: I 'follow her lead'
Tags Make It Schizophrenia Wellness
From CNBC.com News
Thanksgiving Small Bits & Pieces
Tags coronavirus Eli Lilly (LLY) schizophrenia
From Stock Gumshoe
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
Tickers ABBV BMY NEWS
Tags Movers Health Care Market News
From Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
Tickers BMY NEWS RVPH
Tags Briefs BMY General
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Tickers BMY EIX LUCY O
Tags Schizophrenia Exclusives Benzinga
From Benzinga
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
Tickers PMBHF
Tags Penny Stocks PMBHF Psychedelic/Assisted Therapies
From Benzinga
Psychedelics And Schizophrenia: What's The Link?
Tags Market News contributors Cannabis
From Benzinga
Tips on Managing Your Schizophrenia
Tickers ALKS
Tags Education Schizophrenia Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Marketing & Marijuana: Why Responsibility Is So Important As Psychosis & Schizophrenia Among Youth Rise
Tickers CBD CURLF
Tags KQED Regulations Cannabis
From Benzinga
Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders
Tickers ADXN
Tags Health Care Penny Stocks Market News
From Benzinga
Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial
Tickers KRTX
Tags Biotech Benzinga Schizophrenia
From Benzinga
Cannabis Increases Odds Of This Disorder In Teens Despite Infrequent Use
Tags Cannabis contributors Market News
From Benzinga
Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia
Tickers ALKS
Tags News General Market News
From Benzinga
Alkermes Highlights Signs and Symptoms of Schizophrenia
Tags National Institute of Mental Health Alkermes Schizophrenia
From 3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Gives Green Signal To Reviva Pharma's Late-Stage Schizophrenia Trial
Tickers RVPH
Tags RVPH Health Care Movers
From Benzinga
FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders
Tickers BTAI
Tags Market News Health Care Movers
From Benzinga
Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets
Tickers NBIX
Tags Briefs NBIX Biotechnology
From Benzinga
ATAI Life's Schizophrenia Candidate Shows Promising Action In Mid-Stage Study
Tickers ATAI
Tags Benzinga Schizophrenia Phase 2 Trial
From Benzinga
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
Tickers TEVA
Tags Market News TEVA Movers
From Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
Tickers NERV
Tags Health Care Movers Market News
From Benzinga
Alkermes Announces Launch of 4th Annual Alkermes Pathways Research Awards® Program
Tickers ALKS
Tags Alkermes Pathways Research Awards NASDAQ:ALKS alcohol use disorder (AUD)
From 3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Approves First And Only Twice-Yearly Schizophrenia Drug
Tickers JNJ
Tags Health Care Market News JNJ
From Benzinga
Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review
Tickers TEVA
Tags FDA Biotech Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story